SCHEMBL1128541

SCHEMBL1128541

O=Cc1nc(Cl)c(Cl)c(Cl)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20298368 0.78 PDE10A (0.39) —
SCHEMBL8461698 0.73 CCR1 (0.32) —
SCHEMBL3315761 0.73 ALDH1A1 (0.50) —
SCHEMBL24512545 0.72 LMNA (0.33) —
SCHEMBL5674970 0.69 S1PR2 (0.34) —
SCHEMBL17395923 0.67 MEN1 (0.30) —
SCHEMBL218726 0.63 ALDH1A1 (0.54) —
SCHEMBL18301222 0.62 CYP1A2 (0.40) —
SCHEMBL9418468 0.61 POLB (0.35) —
SCHEMBL7992334 0.61 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8188098-B2 GPR119 receptor agonists HOFFMANN-LA ROCHE INC. (US) 2012-05-29 — — US disclosed
CN-102036991-A GPR119 receptor agonists HOFFMANN LA ROCHE 2011-04-27 — — CN disclosed
EP-2283019-A1 GPR119 RECEPTOR AGONISTS F. Hoffmann-La Roche AG (CH) 2011-02-16 — — EP disclosed
WO-2009141238-A1 GPR119 RECEPTOR AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2009-11-26 — — WO disclosed
US-20090286812-A1 GPR119 Receptor Agonists ERICKSON SHAWN DAVID 2009-11-19 — — US disclosed
Send feedback